会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ENHANCEMENT OF THE THERAPEUTIC PROPERTIES OF GLYCOPROTEIN
    • 增加糖蛋白的治疗性质
    • WO1989007641A1
    • 1989-08-24
    • PCT/US1989000458
    • 1989-02-06
    • GENZYME CORPORATION
    • GENZYME CORPORATIONRASMUSSEN, James, R.BERGH, MichelHIRANI, Shirish
    • C12N09/48
    • C12N9/6462C12N9/48C12N9/82C12Y304/21073
    • A mammal in need of administration of a glycoprotein is treated by providing the glycoprotein, treating the glycoprotein with a peptide-N -(N-acetyl- beta -glucosaminyl) asparagine amidase to form a modified glycoprotein, admixing the modified glycoprotein with a pharmaceutically acceptable carrier substance to form a therapeutic composition, and administering a pharmaceutically effective amount of the therapeutic composition to the said mammal. Also, modified human tissue plasminogen activator is prepared by providing human tissue plasminogen activator and treating the human tissue plasminogen activator with a peptide-N -(N-acetyl- beta -glucosaminyl) asparagine amidase to convert the asparagine residue at positon 448 to an aspartate residue, without completely deglycosylating the asparagine residue at position 117. Also, modified prourokinase is prepared by the process of providing prourokinase and treating the prourokinase with a peptide-N -(N-acetyl- beta -glucosaminyl) asparagine amidase to convert the asparagine residue at position 302 to an aspartate residue.
    • 通过提供糖蛋白处理需要施用糖蛋白的哺乳动物,用肽-N 4 - (N-乙酰基-β-葡糖胺酰基)天冬酰胺酰胺酶处理糖蛋白以形成修饰的糖蛋白,将修饰的糖蛋白与 用于形成治疗组合物的药学上可接受的载体物质,以及向所述哺乳动物施用药学上有效量的治疗组合物。 此外,通过提供人组织纤溶酶原激活剂和用肽-N 4 - (N-乙酰基-β-葡糖胺酰基)天冬酰胺酰胺酶处理人组织纤溶酶原激活物以在位置448处转化天冬酰胺残基来制备修饰的人组织纤溶酶原激活物 到天冬氨酸残基,而没有完全去糖基化117位的天冬酰胺残基。此外,通过提供尿激酶原的方法和用肽-N 4 - (N-乙酰基-β-葡糖胺酰基)天冬酰胺处理原尿激酶的方法制备修饰的尿激酶原 将位置302处的天冬酰胺残基转化为天冬氨酸残基的酰胺酶。